Get access

What is the role of covert infection in detrusor overactivity, and other LUTD? ICI-RS 2013


  • Kate H. Moore,

    Corresponding author
    1. Pelvic Floor Unit, Department of Urogynaecology, University of New South Wales, Sydney, NSW, Australia
    • Correspondence to: Kate H. Moore, M.B.B.S., M.D., FRCOG, FRANZCOG, CU, Department of Urogynaecology, University of New South Wales, Level 1, W.R. Pitney Clinical Sciences Building, St. George Hospital, Gray Street, Kogarah, Sydney, NSW 2217, Australia. E-mail:

    Search for more papers by this author
  • Anna P. Malykhina

    1. Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
    Search for more papers by this author

  • Christopher Chapple led the peer-review process as the Associate Editor responsible for the paper.
  • Conflict of interest: none.


A think tank was convened at the fourth ICI-RS meeting, which took place June 5–7, 2013 in Bristol UK, to consider current evidence and controversies surrounding the possible role of ‘covert infection’ in the pathophysiology of refractory detrusor overactivity (DO) and other lower urinary tract disorders (LUTD). The topic was chosen because several authors from different centers worldwide have recently published evidence which supports this concept. However, to date there is inconsistency regarding terminology and microbiological definitions, which were discussed by the participants. The mechanisms whereby infection/inflammation could actually promote aberrant detrusor contractions in the human remain controversial, and are more fully described in this report. Future requirements for research into this topic were outlined. Neurourol. Urodynam. 33:606–610, 2014. © 2014 Wiley Periodicals, Inc.